Lv3
324 积分 2025-05-12 加入
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial
5小时前
已完结
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
5小时前
已完结
The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
5小时前
待确认
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial
5小时前
已完结
Efficacy and safety of camrelizumab combined with chemotherapy versus chemotherapy alone as preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma: Preliminary results from a multicenter, prospective, randomized controlled study
5小时前
求助中
. Efficacy and safety of camrelizumab combined with chemotherapy versus chemotherapy alone as preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma: preliminary results from a multicenter, prospective, randomized controlled study
6小时前
求助中
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
6小时前
已完结
The three Es of cancer immunoediting
26天前
已完结
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art
27天前
已完结
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
30天前
已完结
皖公网安备34019202002308
